Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.
about
Avoiding weight gain in cardiometabolic disease: a systematic reviewToward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its ComplicationsWeight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23).Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in swedenImpact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.Minimizing Hypoglycemia and Weight Gain with Intensive Glucose Control: Potential Benefits of a New Combination Therapy (IDegLira).Insulin Detemir Is Transported From Blood to Cerebrospinal Fluid and Has Prolonged Central Anorectic Action Relative to NPH Insulin.Insulin mediated improvement in glycemic control in elderly with type 2 diabetes mellitus can improve depressive symptoms and does not seem to impair health-related quality of lifeInsulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes.Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in SpainDesign of non-standard insulin analogs for the treatment of diabetes mellitusEfficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.Long-acting basal insulin analogs: latest developments and clinical usefulness.Longitudinal relationships between glycemic status and body mass index in a multiethnic study: evidence from observational and genetic epidemiology.Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry.Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type).Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.Treating the obese diabetic.U300, a novel long-acting insulin formulation.Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin.Association between insulin-induced weight change and CVD mortality: Evidence from a historical cohort study of 18,814 patients in UK Primary Care.Impaired insulin action in the human brain: causes and metabolic consequences.The past, present, and future of basal insulins.GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen.Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes.Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.Prediction of excessive weight gain in insulin treated patients with type 2 diabetes.Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?Management of Type 2 Diabetes in the Setting of Morbid Obesity: How Can Weight Gain Be Prevented or Reversed?Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.Obese Patients with Type 2 Diabetes on Conventional Versus Intensive Insulin Therapy: Efficacy of Low-Calorie Dietary Intervention.Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes.Effect of a group medical clinic for veterans with diabetes on body mass index.Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis.Effects of exenatide twice daily, exenatide once weekly or insulin in patients with type 2 diabetes and baseline HbA1c ≥10.0%: Two pooled analyses including 20 randomised controlled trials.Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin.Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
P2860
Q28081926-28A3F16F-99D4-432D-AE49-7C7E14504B39Q31005299-9DBB6D4C-C81E-41E5-9873-AF5D1C759635Q31120318-3100C3AC-AF96-4818-8D1A-413A1D45EC19Q34276309-8ACFFB1E-C9BB-43B6-9864-FE3978260E12Q34726534-9563CAEA-0F39-4D6D-99BA-8998FBBAF1E3Q35594627-5E935831-BCE9-4FC5-851E-48DC11C89D94Q35666228-5BC78621-F061-46D8-B1A8-54A2F28DBB40Q35769593-F4B236E4-DB72-45B6-9CE3-B43C82C05DD3Q35774430-0BEE3015-760D-430A-B570-B51757E8FFAFQ35988978-964F23F1-F1AF-45EB-B1CC-5737685FF807Q36328097-CA533864-F581-43B8-AD57-91F5E4001C4AQ36360045-75A56D3B-7D17-4DB8-B88D-BD4D9557EAE4Q36374363-037E8B03-4EF1-48E8-97C0-8762E807DC85Q36498624-9657EAFD-A3EE-44FC-A15E-A05C2209884AQ36515474-18A93E5A-B495-41AE-A55C-850A30711300Q37144928-B117DB06-A0A2-4378-93C8-483F74E41685Q37598881-D1228D55-845E-4E4C-B517-D4AD094D1EB4Q37612059-A39867FA-59E8-4319-ADDE-67935D9FEEAAQ37671870-49E6F9D1-84C3-4281-9061-38370A11DD99Q37972941-5C4C7E99-9F17-44BA-89B3-EC663D080C5BQ38087696-601940E6-03B6-422C-9EB5-DE0260D7B91EQ38259756-DF6BF66B-51E9-4213-B5D1-C7197E60B21CQ38378534-D097AA4E-1562-4E45-95E2-1FF588437DCBQ38596961-CE636E4E-DF83-42C8-BE79-BDABA2D2E835Q38605675-FCBBEBCC-C07C-4719-9CF6-C151ED4D5AC5Q38618376-A944DADE-99E5-4764-81F4-82F6AE2D7A8CQ38875894-096E0D81-EB33-443E-9D76-8278DAEC2358Q39101008-6F79F2EC-596B-4CDC-8011-BA61B4D0CD46Q39404106-CC5EF893-1837-47CD-B893-85FC52F2CC6EQ39808718-BE009939-D3D5-47BA-BD2B-394AF0A7ED6AQ39812306-4C0A28BC-EF94-4C3E-ACD4-79AF98BC3FF6Q40236660-E846CC25-1780-4A1E-85D6-D1013B7DD322Q40785914-C35C26F5-114D-4F7A-94C8-0E954E8FF00CQ40904806-BC8AE532-36A3-4DA1-9F41-B901484DF298Q43642531-C247FB0C-92F0-43CF-9FA3-5C4C9C5A4EA0Q47654374-6EA99B70-829D-48DF-AC87-960257DF3308Q47669533-9BA94BFB-94D4-4D76-BC4C-38080001C950Q47769217-F326E57C-B4D1-4638-A69B-E5F2A4C84149Q47770450-30DD72AA-58D3-41CC-80E4-CAAC4BDADE40Q47926176-87D22F86-DA3F-4EE2-817E-B704B0027D8A
P2860
Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Increase of body weight during ...... atic review and meta-analysis.
@en
Increase of body weight during ...... atic review and meta-analysis.
@nl
type
label
Increase of body weight during ...... atic review and meta-analysis.
@en
Increase of body weight during ...... atic review and meta-analysis.
@nl
prefLabel
Increase of body weight during ...... atic review and meta-analysis.
@en
Increase of body weight during ...... atic review and meta-analysis.
@nl
P2093
P2860
P1476
Increase of body weight during ...... atic review and meta-analysis.
@en
P2093
A E Pontiroli
A Morabito
P2860
P304
P356
10.1111/J.1463-1326.2011.01433.X
P577
2011-11-01T00:00:00Z